Compare Linde PLC (LIN) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Linde PLC vs Tempus AI — how do they compare? Linde PLC trades at $490.26 (market cap $227.01B), while Tempus AI trades at $55.55 (market cap $9.93B). The key difference: Linde PLC is far larger — about 22.9× Tempus AI's market cap, and Linde PLC pays a 1.3% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| LIN | TEM | |
|---|---|---|
Market Cap | $227.01B | $9.93B |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $546.64 | $103.25 |
52-Week Low | $389.38 | $41.55 |
Enterprise Value | $250.13B | $10.56B |
Dividend Yield | 1.3% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Linde (LIN) trades at $489.98, showing minimal daily change. The stock exhibits strong fundamentals with consistent earnings beats, a 20.43% net income margin, and robust cash flow. However, technical indicators signal a bearish short-term trend, with the price near the pivot point of $490. Recent news highlights sustainability leadership and Q1 2026 EPS growth of 10% year-over-year, though a DCF analysis from GuruFocus on June 1, 2026, suggested potential overvaluation at a $327 fair value.
The investment outlook is supported by solid profitability and a bullish analyst consensus with a $553.60 price target, but risks include elevated valuation multiples and increasing debt-to-asset ratios. The stock's near-term direction may hinge on Q3 2026 earnings versus the $4.53 estimate, with technical resistance at $493 posing a challenge to upside momentum.
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Linde PLC
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $31 billion in revenue and $5 billion in GAAP operating profit in 2021.
Read more on LIN →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
